

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phenol-containing compound catabolic process (GO:0019336) | 9.23079380 |
| 2 | * detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 8.89514385 |
| 3 | * detection of temperature stimulus involved in sensory perception (GO:0050961) | 8.89514385 |
| 4 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 7.03593160 |
| 5 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 6.76002677 |
| 6 | behavioral response to nicotine (GO:0035095) | 6.66924807 |
| 7 | proline transport (GO:0015824) | 6.60534413 |
| 8 | cell migration in hindbrain (GO:0021535) | 6.18960483 |
| 9 | negative regulation of dendrite morphogenesis (GO:0050774) | 5.78176000 |
| 10 | neurofilament cytoskeleton organization (GO:0060052) | 5.75949897 |
| 11 | peripheral nervous system neuron development (GO:0048935) | 5.48405895 |
| 12 | response to pain (GO:0048265) | 5.38648827 |
| 13 | negative regulation of microtubule polymerization (GO:0031115) | 5.28667422 |
| 14 | behavioral response to ethanol (GO:0048149) | 5.19394907 |
| 15 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.67890476 |
| 16 | neuronal action potential (GO:0019228) | 4.55820539 |
| 17 | negative regulation of bone resorption (GO:0045779) | 4.54756377 |
| 18 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 4.38400456 |
| 19 | synaptic vesicle maturation (GO:0016188) | 4.37511393 |
| 20 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.35933211 |
| 21 | cellular response to interleukin-15 (GO:0071350) | 4.26478430 |
| 22 | response to histamine (GO:0034776) | 4.21363630 |
| 23 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.20483753 |
| 24 | enteric nervous system development (GO:0048484) | 4.20410652 |
| 25 | DNA deamination (GO:0045006) | 4.17471191 |
| 26 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.16776293 |
| 27 | positive regulation of granulocyte differentiation (GO:0030854) | 4.04606787 |
| 28 | regulation of T cell chemotaxis (GO:0010819) | 4.02402171 |
| 29 | positive regulation of T cell chemotaxis (GO:0010820) | 4.02402171 |
| 30 | mitochondrion transport along microtubule (GO:0047497) | 3.96360044 |
| 31 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.96360044 |
| 32 | negative regulation by host of viral transcription (GO:0043922) | 3.95115105 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.94593455 |
| 34 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.94473406 |
| 35 | polyketide metabolic process (GO:0030638) | 3.93441409 |
| 36 | doxorubicin metabolic process (GO:0044598) | 3.93441409 |
| 37 | daunorubicin metabolic process (GO:0044597) | 3.93441409 |
| 38 | response to interleukin-15 (GO:0070672) | 3.90480630 |
| 39 | establishment of mitochondrion localization (GO:0051654) | 3.89828531 |
| 40 | negative regulation of smooth muscle contraction (GO:0045986) | 3.86388001 |
| 41 | synaptic transmission, cholinergic (GO:0007271) | 3.83857975 |
| 42 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.74980432 |
| 43 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.73691610 |
| 44 | neuromuscular synaptic transmission (GO:0007274) | 3.73109340 |
| 45 | definitive hemopoiesis (GO:0060216) | 3.70593868 |
| 46 | negative regulation of dendrite development (GO:2000171) | 3.69373002 |
| 47 | negative regulation of bone remodeling (GO:0046851) | 3.68620858 |
| 48 | G-protein coupled receptor internalization (GO:0002031) | 3.68288809 |
| 49 | membrane depolarization during action potential (GO:0086010) | 3.67919563 |
| 50 | regulation of RIG-I signaling pathway (GO:0039535) | 3.67294975 |
| 51 | * sympathetic nervous system development (GO:0048485) | 3.67018742 |
| 52 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.64823890 |
| 53 | negative regulation of epidermis development (GO:0045683) | 3.63392642 |
| 54 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.61934600 |
| 55 | positive regulation of erythrocyte differentiation (GO:0045648) | 3.60503487 |
| 56 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.60374495 |
| 57 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.54693425 |
| 58 | nuclear pore organization (GO:0006999) | 3.52724207 |
| 59 | nuclear pore complex assembly (GO:0051292) | 3.50942955 |
| 60 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.49578602 |
| 61 | granulocyte differentiation (GO:0030851) | 3.46582547 |
| 62 | peristalsis (GO:0030432) | 3.46028115 |
| 63 | * response to water (GO:0009415) | 3.45219806 |
| 64 | response to acidic pH (GO:0010447) | 3.45146316 |
| 65 | erythrocyte maturation (GO:0043249) | 3.43728926 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 3.40364006 |
| 67 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.36971047 |
| 68 | negative regulation of neurological system process (GO:0031645) | 3.34508016 |
| 69 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.32744777 |
| 70 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.31081189 |
| 71 | catechol-containing compound biosynthetic process (GO:0009713) | 3.30831462 |
| 72 | catecholamine biosynthetic process (GO:0042423) | 3.30831462 |
| 73 | regulation of erythrocyte differentiation (GO:0045646) | 3.28666163 |
| 74 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.28614888 |
| 75 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.28614888 |
| 76 | cell communication involved in cardiac conduction (GO:0086065) | 3.26864239 |
| 77 | coenzyme catabolic process (GO:0009109) | 3.23016365 |
| 78 | negative regulation of heart rate (GO:0010459) | 3.22853929 |
| 79 | oxygen transport (GO:0015671) | 3.21994394 |
| 80 | response to dietary excess (GO:0002021) | 3.21460893 |
| 81 | negative regulation of interleukin-2 production (GO:0032703) | 3.19628757 |
| 82 | multicellular organismal response to stress (GO:0033555) | 3.19236522 |
| 83 | modulation by host of viral transcription (GO:0043921) | 3.19041944 |
| 84 | modulation by host of symbiont transcription (GO:0052472) | 3.19041944 |
| 85 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.18671704 |
| 86 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.17195287 |
| 87 | dopamine metabolic process (GO:0042417) | 3.16788705 |
| 88 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16787356 |
| 89 | neurotransmitter catabolic process (GO:0042135) | 3.15326372 |
| 90 | protein polyglutamylation (GO:0018095) | 3.11680057 |
| 91 | norepinephrine metabolic process (GO:0042415) | 3.10507301 |
| 92 | microtubule depolymerization (GO:0007019) | 3.07557844 |
| 93 | negative regulation of tissue remodeling (GO:0034104) | 3.07050441 |
| 94 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.06454418 |
| 95 | melanosome transport (GO:0032402) | 3.06091965 |
| 96 | action potential (GO:0001508) | 3.05452949 |
| 97 | alanine transport (GO:0032328) | 3.05361878 |
| 98 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.04232989 |
| 99 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.02743364 |
| 100 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.02319588 |
| 101 | axon cargo transport (GO:0008088) | 3.00572135 |
| 102 | glutamate secretion (GO:0014047) | 3.00539415 |
| 103 | positive regulation of growth hormone secretion (GO:0060124) | 3.00307219 |
| 104 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.00222054 |
| 105 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.00043680 |
| 106 | gas transport (GO:0015669) | 2.99536608 |
| 107 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 2.99256475 |
| 108 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 2.98472552 |
| 109 | mRNA cleavage (GO:0006379) | 2.95469438 |
| 110 | maintenance of protein location in nucleus (GO:0051457) | 2.95092449 |
| 111 | pore complex assembly (GO:0046931) | 2.93821752 |
| 112 | regulation of chronic inflammatory response (GO:0002676) | 2.93713431 |
| 113 | retinal ganglion cell axon guidance (GO:0031290) | 2.92335291 |
| 114 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.90288977 |
| 115 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.88549319 |
| 116 | establishment of melanosome localization (GO:0032401) | 2.88254019 |
| 117 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.87514165 |
| 118 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.87340321 |
| 119 | pigment granule transport (GO:0051904) | 2.87060809 |
| 120 | positive regulation of odontogenesis (GO:0042482) | 2.86591730 |
| 121 | positive regulation of glycolytic process (GO:0045821) | 2.85930597 |
| 122 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.85921164 |
| 123 | dopamine biosynthetic process (GO:0042416) | 2.84443159 |
| 124 | erythrocyte development (GO:0048821) | 2.83437481 |
| 125 | iron coordination entity transport (GO:1901678) | 2.81377752 |
| 126 | urinary tract smooth muscle contraction (GO:0014848) | 2.80515096 |
| 127 | dopamine receptor signaling pathway (GO:0007212) | 2.79916176 |
| 128 | positive regulation of axon extension (GO:0045773) | 2.79059018 |
| 129 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.78810505 |
| 130 | tolerance induction (GO:0002507) | 2.77575052 |
| 131 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.76305727 |
| 132 | sodium ion transmembrane transport (GO:0035725) | 2.75708645 |
| 133 | catecholamine transport (GO:0051937) | 2.75265596 |
| 134 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.71760810 |
| 135 | establishment of pigment granule localization (GO:0051905) | 2.70898731 |
| 136 | positive regulation of protein sumoylation (GO:0033235) | 2.70702174 |
| 137 | positive regulation of macrophage differentiation (GO:0045651) | 2.70356300 |
| 138 | cytidine metabolic process (GO:0046087) | 2.68812687 |
| 139 | cytidine catabolic process (GO:0006216) | 2.68812687 |
| 140 | cytidine deamination (GO:0009972) | 2.68812687 |
| 141 | synaptic vesicle exocytosis (GO:0016079) | 2.68688919 |
| 142 | regulation of hair follicle development (GO:0051797) | 2.68661736 |
| 143 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.67529222 |
| 144 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.67529222 |
| 145 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.67238353 |
| 146 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.65946949 |
| 147 | auditory behavior (GO:0031223) | 2.65708713 |
| 148 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.65106495 |
| 149 | negative regulation of catecholamine secretion (GO:0033604) | 2.65075974 |
| 150 | organelle transport along microtubule (GO:0072384) | 2.64295193 |
| 151 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.63440774 |
| 152 | neuronal action potential propagation (GO:0019227) | 2.63337827 |
| 153 | regulation of striated muscle cell apoptotic process (GO:0010662) | 2.63216956 |
| 154 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.63147501 |
| 155 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.63147501 |
| 156 | T cell differentiation involved in immune response (GO:0002292) | 2.63147501 |
| 157 | membrane budding (GO:0006900) | 2.61542303 |
| 158 | melanosome localization (GO:0032400) | 2.60735316 |
| 159 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.60419920 |
| 160 | tachykinin receptor signaling pathway (GO:0007217) | 2.60274459 |
| 161 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.59302173 |
| 162 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 2.58561929 |
| 163 | regulation of circadian sleep/wake cycle (GO:0042749) | 2.58561929 |
| 164 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.54091556 |
| 165 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.54091556 |
| 166 | termination of RNA polymerase II transcription (GO:0006369) | 2.52177102 |
| 167 | diterpenoid biosynthetic process (GO:0016102) | 2.51169766 |
| 168 | T-helper cell differentiation (GO:0042093) | 2.46010524 |
| 169 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.46010524 |
| 170 | regulation of synapse structural plasticity (GO:0051823) | 2.45995110 |
| 171 | metallo-sulfur cluster assembly (GO:0031163) | 2.44666109 |
| 172 | iron-sulfur cluster assembly (GO:0016226) | 2.44666109 |
| 173 | megakaryocyte development (GO:0035855) | 2.43964518 |
| 174 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.43697622 |
| 175 | replication fork processing (GO:0031297) | 2.42620317 |
| 176 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.42281924 |
| 177 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.41792413 |
| 178 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.41142190 |
| 179 | glycine transport (GO:0015816) | 2.41025989 |
| 180 | arginine catabolic process (GO:0006527) | 2.40573107 |
| 181 | viral mRNA export from host cell nucleus (GO:0046784) | 2.38970998 |
| 182 | synaptic transmission, dopaminergic (GO:0001963) | 2.38048699 |
| 183 | regulation of exit from mitosis (GO:0007096) | 2.37201040 |
| 184 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.36043466 |
| 185 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.35846514 |
| 186 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.35695121 |
| 187 | * detection of temperature stimulus (GO:0016048) | 10.0361336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 5.77619287 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.34775725 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.60571806 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.60571806 |
| 5 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.60571806 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.46041505 |
| 7 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 3.30918810 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.94612797 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.86810723 |
| 10 | GATA1_19941826_ChIP-Seq_K562_Human | 2.77664534 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.70298964 |
| 12 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.63705430 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.60679446 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.59767219 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.58002543 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.34634324 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.34124291 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.33782837 |
| 19 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.27680387 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.18679494 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.18304241 |
| 22 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.17624637 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.17483042 |
| 24 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.17443915 |
| 25 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.16463733 |
| 26 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.14540649 |
| 27 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 2.11523731 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.10483381 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.09504345 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.07577002 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.07239617 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.07239617 |
| 33 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.06033401 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.05962807 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.05012804 |
| 36 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.99039378 |
| 37 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.98738213 |
| 38 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.97909247 |
| 39 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.97073362 |
| 40 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.96801013 |
| 41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.95038226 |
| 42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95001878 |
| 43 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.94124256 |
| 44 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.92872513 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.92598824 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.88326279 |
| 47 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.85338291 |
| 48 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85139491 |
| 49 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.84516868 |
| 50 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.83860875 |
| 51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.83059920 |
| 52 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.82506068 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.82179981 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81787303 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.80190572 |
| 56 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.78951580 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77415296 |
| 58 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.75501223 |
| 59 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.74067266 |
| 60 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.71581492 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69808492 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68840343 |
| 63 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.68332894 |
| 64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.68064560 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67146389 |
| 66 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.66505939 |
| 67 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.66270663 |
| 68 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.64735781 |
| 69 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.64257047 |
| 70 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.59360708 |
| 71 | MYB_26560356_Chip-Seq_TH2_Human | 1.59276267 |
| 72 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.58609625 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58557281 |
| 74 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57682648 |
| 75 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.57331506 |
| 76 | MYC_22102868_ChIP-Seq_BL_Human | 1.56762341 |
| 77 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.56623012 |
| 78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.55184524 |
| 79 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.53587891 |
| 80 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.53450730 |
| 81 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52140392 |
| 82 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.52048448 |
| 83 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.49701806 |
| 84 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47241246 |
| 85 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.45777764 |
| 86 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.44620473 |
| 87 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.42856978 |
| 88 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.40253818 |
| 89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.40252298 |
| 90 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40224179 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.39735702 |
| 92 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.37580521 |
| 93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36895902 |
| 94 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.35292282 |
| 95 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.34551859 |
| 96 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34511563 |
| 97 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.34434318 |
| 98 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32440896 |
| 99 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31723328 |
| 100 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.31574800 |
| 101 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.27940638 |
| 102 | MAF_26560356_Chip-Seq_TH1_Human | 1.27679231 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.26199464 |
| 104 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26189285 |
| 105 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25909492 |
| 106 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25241617 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25165951 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24629214 |
| 109 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.24600477 |
| 110 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.23696281 |
| 111 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22999157 |
| 112 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22405305 |
| 113 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.21408805 |
| 114 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21377292 |
| 115 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.21001317 |
| 116 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.20823114 |
| 117 | MYB_26560356_Chip-Seq_TH1_Human | 1.19431744 |
| 118 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.19336712 |
| 119 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19306690 |
| 120 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.19198695 |
| 121 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.18149241 |
| 122 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18094315 |
| 123 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.18026233 |
| 124 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17608384 |
| 125 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.17411089 |
| 126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17305381 |
| 127 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16923188 |
| 128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16915727 |
| 129 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.16172778 |
| 130 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.15631735 |
| 131 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15471016 |
| 132 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15358918 |
| 133 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14440851 |
| 134 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.13698429 |
| 135 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13325531 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12933151 |
| 137 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12927720 |
| 138 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12686422 |
| 139 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.12449205 |
| 140 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11987369 |
| 141 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11829823 |
| 142 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11780959 |
| 143 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.11047984 |
| 144 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.09848577 |
| 145 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.08974064 |
| 146 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.07661077 |
| 147 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07270781 |
| 148 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07193949 |
| 149 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06573944 |
| 150 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.06403559 |
| 151 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05233277 |
| 152 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04179203 |
| 153 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03854396 |
| 154 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03370040 |
| 155 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.03269729 |
| 156 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.03229324 |
| 157 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01979773 |
| 158 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.01849984 |
| 159 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01781791 |
| 160 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01347695 |
| 161 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00480741 |
| 162 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.99046625 |
| 163 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.98581110 |
| 164 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98554268 |
| 165 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.97406410 |
| 166 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.96217387 |
| 167 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94967271 |
| 168 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.94962000 |
| 169 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.94809920 |
| 170 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94514069 |
| 171 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.94271291 |
| 172 | * MAF_26560356_Chip-Seq_TH2_Human | 0.94122801 |
| 173 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.93978021 |
| 174 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.92278452 |
| 175 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.91218419 |
| 176 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.91182431 |
| 177 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91138571 |
| 178 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90688231 |
| 179 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.90377084 |
| 180 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.89636244 |
| 181 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89286732 |
| 182 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88794385 |
| 183 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88739649 |
| 184 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.88167298 |
| 185 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.87539195 |
| 186 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.87516407 |
| 187 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.86090039 |
| 188 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.85931464 |
| 189 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85542159 |
| 190 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.84999577 |
| 191 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.84835766 |
| 192 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82070329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 6.96209078 |
| 2 | MP0004858_abnormal_nervous_system | 6.62892427 |
| 3 | MP0002822_catalepsy | 4.97993749 |
| 4 | MP0001968_abnormal_touch/_nociception | 4.47641790 |
| 5 | * MP0006276_abnormal_autonomic_nervous | 4.44803940 |
| 6 | * MP0002733_abnormal_thermal_nociception | 3.83304957 |
| 7 | MP0004147_increased_porphyrin_level | 3.75068613 |
| 8 | * MP0001970_abnormal_pain_threshold | 3.48498624 |
| 9 | MP0002736_abnormal_nociception_after | 3.20574462 |
| 10 | * MP0002734_abnormal_mechanical_nocicepti | 3.07261880 |
| 11 | MP0001986_abnormal_taste_sensitivity | 3.03976316 |
| 12 | MP0002009_preneoplasia | 3.00381086 |
| 13 | * MP0004270_analgesia | 2.92894188 |
| 14 | MP0001188_hyperpigmentation | 2.89307391 |
| 15 | MP0010386_abnormal_urinary_bladder | 2.71870297 |
| 16 | MP0005671_abnormal_response_to | 2.51560175 |
| 17 | MP0008995_early_reproductive_senescence | 2.44268578 |
| 18 | * MP0002751_abnormal_autonomic_nervous | 2.43019006 |
| 19 | MP0002184_abnormal_innervation | 2.39292982 |
| 20 | MP0008058_abnormal_DNA_repair | 2.02225777 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.01012039 |
| 22 | MP0001348_abnormal_lacrimal_gland | 1.93356346 |
| 23 | MP0003567_abnormal_fetal_cardiomyocyte | 1.86490598 |
| 24 | MP0003786_premature_aging | 1.84754187 |
| 25 | MP0003122_maternal_imprinting | 1.84391266 |
| 26 | MP0003693_abnormal_embryo_hatching | 1.79362952 |
| 27 | MP0004859_abnormal_synaptic_plasticity | 1.79114115 |
| 28 | MP0008057_abnormal_DNA_replication | 1.77244535 |
| 29 | MP0009745_abnormal_behavioral_response | 1.76622378 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.75782236 |
| 31 | MP0002272_abnormal_nervous_system | 1.74190691 |
| 32 | MP0003011_delayed_dark_adaptation | 1.71426870 |
| 33 | MP0001270_distended_abdomen | 1.67776063 |
| 34 | MP0000955_abnormal_spinal_cord | 1.66184427 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.65354637 |
| 36 | MP0001905_abnormal_dopamine_level | 1.61711025 |
| 37 | MP0005499_abnormal_olfactory_system | 1.61226892 |
| 38 | MP0005394_taste/olfaction_phenotype | 1.61226892 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.60310139 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.57879709 |
| 41 | MP0003635_abnormal_synaptic_transmissio | 1.57741901 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.56054138 |
| 43 | MP0002398_abnormal_bone_marrow | 1.54577150 |
| 44 | MP0002572_abnormal_emotion/affect_behav | 1.53208616 |
| 45 | MP0010094_abnormal_chromosome_stability | 1.52554595 |
| 46 | MP0008872_abnormal_physiological_respon | 1.50919758 |
| 47 | MP0009046_muscle_twitch | 1.50677915 |
| 48 | MP0003866_abnormal_defecation | 1.49881717 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.49696099 |
| 50 | MP0001440_abnormal_grooming_behavior | 1.49231816 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.45618830 |
| 52 | MP0003329_amyloid_beta_deposits | 1.42729204 |
| 53 | MP0003111_abnormal_nucleus_morphology | 1.41031409 |
| 54 | MP0004811_abnormal_neuron_physiology | 1.40900570 |
| 55 | MP0002909_abnormal_adrenal_gland | 1.40379660 |
| 56 | MP0002102_abnormal_ear_morphology | 1.39411292 |
| 57 | MP0002063_abnormal_learning/memory/cond | 1.39241505 |
| 58 | * MP0002067_abnormal_sensory_capabilities | 1.37320329 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.36621142 |
| 60 | MP0001727_abnormal_embryo_implantation | 1.36057848 |
| 61 | MP0000538_abnormal_urinary_bladder | 1.33800182 |
| 62 | MP0002254_reproductive_system_inflammat | 1.28820420 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.28096127 |
| 64 | MP0010307_abnormal_tumor_latency | 1.27523995 |
| 65 | MP0002064_seizures | 1.27504272 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.23606396 |
| 67 | MP0005253_abnormal_eye_physiology | 1.22814153 |
| 68 | MP0002722_abnormal_immune_system | 1.22356269 |
| 69 | MP0000689_abnormal_spleen_morphology | 1.20525590 |
| 70 | MP0004883_abnormal_blood_vessel | 1.19933933 |
| 71 | * MP0002723_abnormal_immune_serum | 1.12438949 |
| 72 | MP0000749_muscle_degeneration | 1.12353522 |
| 73 | MP0004957_abnormal_blastocyst_morpholog | 1.10490590 |
| 74 | * MP0002429_abnormal_blood_cell | 1.09810839 |
| 75 | MP0002127_abnormal_cardiovascular_syste | 1.08857497 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.07282082 |
| 77 | MP0004924_abnormal_behavior | 1.07282082 |
| 78 | MP0001542_abnormal_bone_strength | 1.07149272 |
| 79 | * MP0002882_abnormal_neuron_morphology | 1.04824934 |
| 80 | MP0001502_abnormal_circadian_rhythm | 1.03793179 |
| 81 | MP0003077_abnormal_cell_cycle | 1.03573269 |
| 82 | MP0004085_abnormal_heartbeat | 1.03309818 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 1.03105785 |
| 84 | MP0000778_abnormal_nervous_system | 1.02929499 |
| 85 | MP0008874_decreased_physiological_sensi | 1.01322282 |
| 86 | MP0003633_abnormal_nervous_system | 0.99534055 |
| 87 | * MP0002420_abnormal_adaptive_immunity | 0.99372082 |
| 88 | * MP0002752_abnormal_somatic_nervous | 0.99212181 |
| 89 | * MP0001819_abnormal_immune_cell | 0.99141360 |
| 90 | MP0001919_abnormal_reproductive_system | 0.97604416 |
| 91 | * MP0000716_abnormal_immune_system | 0.97586852 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.96188372 |
| 93 | MP0005645_abnormal_hypothalamus_physiol | 0.96164078 |
| 94 | MP0001835_abnormal_antigen_presentation | 0.95714894 |
| 95 | MP0005000_abnormal_immune_tolerance | 0.95225076 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.94829126 |
| 97 | MP0005647_abnormal_sex_gland | 0.94069579 |
| 98 | MP0002653_abnormal_ependyma_morphology | 0.93708316 |
| 99 | MP0000534_abnormal_ureter_morphology | 0.92793911 |
| 100 | * MP0001800_abnormal_humoral_immune | 0.91837247 |
| 101 | MP0004264_abnormal_extraembryonic_tissu | 0.91778285 |
| 102 | MP0002210_abnormal_sex_determination | 0.90187443 |
| 103 | MP0002396_abnormal_hematopoietic_system | 0.89870103 |
| 104 | MP0003718_maternal_effect | 0.88634628 |
| 105 | MP0001119_abnormal_female_reproductive | 0.87034780 |
| 106 | MP0009379_abnormal_foot_pigmentation | 0.86835819 |
| 107 | MP0004142_abnormal_muscle_tone | 0.86688887 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.85024871 |
| 109 | MP0005083_abnormal_biliary_tract | 0.84853515 |
| 110 | MP0001756_abnormal_urination | 0.83914624 |
| 111 | MP0005397_hematopoietic_system_phenotyp | 0.83693092 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.83693092 |
| 113 | MP0001501_abnormal_sleep_pattern | 0.81326770 |
| 114 | MP0002229_neurodegeneration | 0.81231626 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.80043336 |
| 116 | MP0008007_abnormal_cellular_replicative | 0.79037386 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.79023442 |
| 118 | MP0008789_abnormal_olfactory_epithelium | 0.79011848 |
| 119 | MP0008932_abnormal_embryonic_tissue | 0.78086265 |
| 120 | MP0004742_abnormal_vestibular_system | 0.78042586 |
| 121 | MP0003631_nervous_system_phenotype | 0.78000774 |
| 122 | MP0002163_abnormal_gland_morphology | 0.77937335 |
| 123 | MP0003646_muscle_fatigue | 0.77607093 |
| 124 | MP0000653_abnormal_sex_gland | 0.77351716 |
| 125 | MP0008569_lethality_at_weaning | 0.76233638 |
| 126 | MP0001790_abnormal_immune_system | 0.75881540 |
| 127 | MP0005387_immune_system_phenotype | 0.75881540 |
| 128 | MP0005310_abnormal_salivary_gland | 0.75813504 |
| 129 | * MP0002066_abnormal_motor_capabilities/c | 0.75682787 |
| 130 | MP0001929_abnormal_gametogenesis | 0.75168917 |
| 131 | MP0003634_abnormal_glial_cell | 0.75098462 |
| 132 | MP0001529_abnormal_vocalization | 0.74912029 |
| 133 | MP0008260_abnormal_autophagy | 0.74703693 |
| 134 | MP0003724_increased_susceptibility_to | 0.74651450 |
| 135 | MP0001873_stomach_inflammation | 0.74598595 |
| 136 | MP0003890_abnormal_embryonic-extraembry | 0.74514232 |
| 137 | MP0005423_abnormal_somatic_nervous | 0.74182086 |
| 138 | MP0005410_abnormal_fertilization | 0.73332790 |
| 139 | MP0002877_abnormal_melanocyte_morpholog | 0.73331809 |
| 140 | MP0006292_abnormal_olfactory_placode | 0.71175198 |
| 141 | MP0000313_abnormal_cell_death | 0.70262406 |
| 142 | MP0000751_myopathy | 0.69453205 |
| 143 | MP0001661_extended_life_span | 0.68786721 |
| 144 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68468623 |
| 145 | MP0008775_abnormal_heart_ventricle | 0.67944492 |
| 146 | MP0003698_abnormal_male_reproductive | 0.67095319 |
| 147 | MP0001145_abnormal_male_reproductive | 0.66616104 |
| 148 | MP0005391_vision/eye_phenotype | 0.66567075 |
| 149 | MP0009764_decreased_sensitivity_to | 0.66263477 |
| 150 | MP0001984_abnormal_olfaction | 0.66208400 |
| 151 | MP0002557_abnormal_social/conspecific_i | 0.65903074 |
| 152 | MP0000747_muscle_weakness | 0.65116260 |
| 153 | MP0002160_abnormal_reproductive_system | 0.64334563 |
| 154 | MP0000604_amyloidosis | 0.64008856 |
| 155 | MP0009765_abnormal_xenobiotic_induced | 0.62885583 |
| 156 | MP0003942_abnormal_urinary_system | 0.62087406 |
| 157 | * MP0002452_abnormal_antigen_presenting | 0.62009753 |
| 158 | MP0000762_abnormal_tongue_morphology | 0.58915532 |
| 159 | MP0002269_muscular_atrophy | 0.58659310 |
| 160 | MP0008770_decreased_survivor_rate | 0.56562764 |
| 161 | MP0003632_abnormal_nervous_system | 0.56213202 |
| 162 | MP0003938_abnormal_ear_development | 0.54430603 |
| 163 | MP0001943_abnormal_respiration | 0.53751790 |
| 164 | MP0001486_abnormal_startle_reflex | 0.52928508 |
| 165 | MP0003121_genomic_imprinting | 0.51577112 |
| 166 | MP0003283_abnormal_digestive_organ | 0.50689858 |
| 167 | MP0003279_aneurysm | 0.49150401 |
| 168 | MP0005535_abnormal_body_temperature | 0.48786653 |
| 169 | * MP0000759_abnormal_skeletal_muscle | 0.47835826 |
| 170 | MP0002069_abnormal_eating/drinking_beha | 0.47402320 |
| 171 | MP0001299_abnormal_eye_distance/ | 0.46988093 |
| 172 | MP0001963_abnormal_hearing_physiology | 0.46383978 |
| 173 | * MP0005197_abnormal_uvea_morphology | 0.43366008 |
| 174 | MP0005257_abnormal_intraocular_pressure | 0.43276364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypothermia (HP:0002045) | 8.07539928 |
| 2 | Ulnar claw (HP:0001178) | 6.44829348 |
| 3 | Myokymia (HP:0002411) | 5.77697217 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.39533679 |
| 5 | Action tremor (HP:0002345) | 5.18041709 |
| 6 | Abnormality of the lower motor neuron (HP:0002366) | 4.62736711 |
| 7 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 4.15320986 |
| 8 | Amblyopia (HP:0000646) | 4.14467300 |
| 9 | Termporal pattern (HP:0011008) | 4.12281075 |
| 10 | Insidious onset (HP:0003587) | 4.12281075 |
| 11 | Bilateral microphthalmos (HP:0007633) | 3.90326113 |
| 12 | * Abnormal autonomic nervous system physiology (HP:0012332) | 3.81255851 |
| 13 | Abnormal gallbladder physiology (HP:0012438) | 3.68813638 |
| 14 | Cholecystitis (HP:0001082) | 3.68813638 |
| 15 | Abnormality of the corticospinal tract (HP:0002492) | 3.66379058 |
| 16 | * Impaired pain sensation (HP:0007328) | 3.52243511 |
| 17 | * Abnormality of pain sensation (HP:0010832) | 3.52243511 |
| 18 | Steppage gait (HP:0003376) | 3.44278329 |
| 19 | Reticulocytosis (HP:0001923) | 3.43642186 |
| 20 | Myotonia (HP:0002486) | 3.42372145 |
| 21 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.36012134 |
| 22 | T lymphocytopenia (HP:0005403) | 3.34968998 |
| 23 | Abnormality of T cell number (HP:0011839) | 3.28448525 |
| 24 | Pheochromocytoma (HP:0002666) | 3.22116602 |
| 25 | Atonic seizures (HP:0010819) | 3.15813142 |
| 26 | Febrile seizures (HP:0002373) | 3.09394940 |
| 27 | Hepatoblastoma (HP:0002884) | 3.08130363 |
| 28 | Focal seizures (HP:0007359) | 3.07566985 |
| 29 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.06591786 |
| 30 | Abnormality of macular pigmentation (HP:0008002) | 3.00932545 |
| 31 | Foot dorsiflexor weakness (HP:0009027) | 2.97337407 |
| 32 | Hammertoe (HP:0001765) | 2.96777080 |
| 33 | Failure to thrive in infancy (HP:0001531) | 2.95986504 |
| 34 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.95885059 |
| 35 | Neonatal hypoglycemia (HP:0001998) | 2.92901357 |
| 36 | Neuroendocrine neoplasm (HP:0100634) | 2.91566131 |
| 37 | Granulocytopenia (HP:0001913) | 2.89294869 |
| 38 | * Orthostatic hypotension (HP:0001278) | 2.88549028 |
| 39 | Distal sensory impairment (HP:0002936) | 2.86217378 |
| 40 | Type 2 muscle fiber atrophy (HP:0003554) | 2.85429294 |
| 41 | Bradycardia (HP:0001662) | 2.84965925 |
| 42 | Supranuclear gaze palsy (HP:0000605) | 2.82187648 |
| 43 | Ankle clonus (HP:0011448) | 2.81832835 |
| 44 | EMG: neuropathic changes (HP:0003445) | 2.80852758 |
| 45 | Sensory axonal neuropathy (HP:0003390) | 2.79081407 |
| 46 | Increased IgM level (HP:0003496) | 2.77065750 |
| 47 | * Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.76496029 |
| 48 | Seborrheic dermatitis (HP:0001051) | 2.76298376 |
| 49 | Hyporeflexia of lower limbs (HP:0002600) | 2.75412378 |
| 50 | Cortical dysplasia (HP:0002539) | 2.73324015 |
| 51 | Stomatitis (HP:0010280) | 2.72078438 |
| 52 | Truncus arteriosus (HP:0001660) | 2.69085830 |
| 53 | Abnormality of reticulocytes (HP:0004312) | 2.69061403 |
| 54 | Abnormality of DNA repair (HP:0003254) | 2.65471855 |
| 55 | Paralysis (HP:0003470) | 2.64433875 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.63748565 |
| 57 | Muscle fiber atrophy (HP:0100295) | 2.63455392 |
| 58 | Limb dystonia (HP:0002451) | 2.63104602 |
| 59 | IgG deficiency (HP:0004315) | 2.62974870 |
| 60 | Exotropia (HP:0000577) | 2.61610528 |
| 61 | Chromsome breakage (HP:0040012) | 2.60640112 |
| 62 | Abnormality of the foot musculature (HP:0001436) | 2.60508837 |
| 63 | Abnormality of T cells (HP:0002843) | 2.60441532 |
| 64 | Neuroblastic tumors (HP:0004376) | 2.55705716 |
| 65 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 2.55705716 |
| 66 | Neuroblastoma (HP:0003006) | 2.55705716 |
| 67 | Primitive neuroectodermal tumor (HP:0030065) | 2.55705716 |
| 68 | 3-Methylglutaconic aciduria (HP:0003535) | 2.54441077 |
| 69 | Abnormality of eosinophils (HP:0001879) | 2.53674225 |
| 70 | Fasciculations (HP:0002380) | 2.53284852 |
| 71 | Ileus (HP:0002595) | 2.52333527 |
| 72 | Horizontal nystagmus (HP:0000666) | 2.50588392 |
| 73 | Impaired proprioception (HP:0010831) | 2.50323416 |
| 74 | Aplastic anemia (HP:0001915) | 2.48916739 |
| 75 | Onion bulb formation (HP:0003383) | 2.47408941 |
| 76 | Hand muscle atrophy (HP:0009130) | 2.47306472 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 2.46007397 |
| 78 | Hypoventilation (HP:0002791) | 2.45622887 |
| 79 | Hypophosphatemic rickets (HP:0004912) | 2.42963276 |
| 80 | External ophthalmoplegia (HP:0000544) | 2.40191805 |
| 81 | Generalized hypotonia (HP:0001290) | 2.39002068 |
| 82 | Areflexia of lower limbs (HP:0002522) | 2.37654205 |
| 83 | Upper limb muscle weakness (HP:0003484) | 2.35978640 |
| 84 | Hypercortisolism (HP:0001578) | 2.34984535 |
| 85 | Difficulty running (HP:0009046) | 2.33847540 |
| 86 | Poikilocytosis (HP:0004447) | 2.32932202 |
| 87 | Eosinophilia (HP:0001880) | 2.32000158 |
| 88 | Abnormality of the musculature of the hand (HP:0001421) | 2.31284289 |
| 89 | Severe combined immunodeficiency (HP:0004430) | 2.31001400 |
| 90 | Multiple enchondromatosis (HP:0005701) | 2.29257016 |
| 91 | Cerebral palsy (HP:0100021) | 2.25503808 |
| 92 | Prolonged bleeding time (HP:0003010) | 2.24951008 |
| 93 | Cholelithiasis (HP:0001081) | 2.24883481 |
| 94 | Rapidly progressive (HP:0003678) | 2.23910619 |
| 95 | Dialeptic seizures (HP:0011146) | 2.22416200 |
| 96 | Muscle fibrillation (HP:0010546) | 2.20843705 |
| 97 | Hyperbilirubinemia (HP:0002904) | 2.20730234 |
| 98 | Increased connective tissue (HP:0009025) | 2.20118728 |
| 99 | Resting tremor (HP:0002322) | 2.19607748 |
| 100 | Decreased motor nerve conduction velocity (HP:0003431) | 2.19291673 |
| 101 | Horseshoe kidney (HP:0000085) | 2.18036525 |
| 102 | Curly hair (HP:0002212) | 2.17779480 |
| 103 | Abnormality of the vocal cords (HP:0008777) | 2.16759521 |
| 104 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.16417149 |
| 105 | Apathy (HP:0000741) | 2.16298707 |
| 106 | Generalized tonic-clonic seizures (HP:0002069) | 2.15687375 |
| 107 | Recurrent viral infections (HP:0004429) | 2.13672830 |
| 108 | Acute encephalopathy (HP:0006846) | 2.12484446 |
| 109 | Amyotrophic lateral sclerosis (HP:0007354) | 2.12053901 |
| 110 | Ragged-red muscle fibers (HP:0003200) | 2.09086713 |
| 111 | Impulsivity (HP:0100710) | 2.08433369 |
| 112 | Abnormal number of erythroid precursors (HP:0012131) | 2.08403698 |
| 113 | * Dysautonomia (HP:0002459) | 2.08020773 |
| 114 | Limb hypertonia (HP:0002509) | 2.07544759 |
| 115 | Partial agenesis of the corpus callosum (HP:0001338) | 2.07312858 |
| 116 | Leukocytosis (HP:0001974) | 2.07248026 |
| 117 | Spastic gait (HP:0002064) | 2.06224601 |
| 118 | Duplicated collecting system (HP:0000081) | 2.05829761 |
| 119 | Homocystinuria (HP:0002156) | 2.04486434 |
| 120 | Abnormality of homocysteine metabolism (HP:0010919) | 2.04486434 |
| 121 | Distal upper limb amyotrophy (HP:0007149) | 2.04289769 |
| 122 | Upper limb amyotrophy (HP:0009129) | 2.04289769 |
| 123 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.02191331 |
| 124 | Postural tremor (HP:0002174) | 1.99631439 |
| 125 | Patellar aplasia (HP:0006443) | 1.99455740 |
| 126 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.98876804 |
| 127 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.98846170 |
| 128 | Hypoplasia of the brainstem (HP:0002365) | 1.98846170 |
| 129 | Abnormality of the renal collecting system (HP:0004742) | 1.96483447 |
| 130 | Abnormal gallbladder morphology (HP:0012437) | 1.96237820 |
| 131 | Progressive cerebellar ataxia (HP:0002073) | 1.95973931 |
| 132 | Hypoproteinemia (HP:0003075) | 1.95070097 |
| 133 | Focal motor seizures (HP:0011153) | 1.94755699 |
| 134 | Lower limb muscle weakness (HP:0007340) | 1.93473722 |
| 135 | Optic nerve coloboma (HP:0000588) | 1.93181026 |
| 136 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.93093744 |
| 137 | Myelodysplasia (HP:0002863) | 1.92973557 |
| 138 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.91531227 |
| 139 | Nervous tissue neoplasm (HP:0030060) | 1.91199908 |
| 140 | Neuroectodermal neoplasm (HP:0030061) | 1.91199908 |
| 141 | Neuroepithelial neoplasm (HP:0030063) | 1.91199908 |
| 142 | Delusions (HP:0000746) | 1.91168395 |
| 143 | Hypokinesia (HP:0002375) | 1.91062649 |
| 144 | Renal Fanconi syndrome (HP:0001994) | 1.90835431 |
| 145 | Dyschromatopsia (HP:0007641) | 1.90550643 |
| 146 | Increased CSF protein (HP:0002922) | 1.90293124 |
| 147 | Diminished motivation (HP:0000745) | 1.89921041 |
| 148 | Abnormality of T cell physiology (HP:0011840) | 1.89476872 |
| 149 | Abnormality of oral frenula (HP:0000190) | 1.89090656 |
| 150 | Absence seizures (HP:0002121) | 1.88983629 |
| 151 | Tetraplegia (HP:0002445) | 1.88811983 |
| 152 | CNS hypomyelination (HP:0003429) | 1.88751093 |
| 153 | Depression (HP:0000716) | 1.87870066 |
| 154 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.87586351 |
| 155 | Chronic diarrhea (HP:0002028) | 1.87214199 |
| 156 | Neoplasm of the heart (HP:0100544) | 1.87053238 |
| 157 | Peripheral hypomyelination (HP:0007182) | 1.86378021 |
| 158 | Urinary urgency (HP:0000012) | 1.86056884 |
| 159 | Neonatal onset (HP:0003623) | 1.85177830 |
| 160 | Type I transferrin isoform profile (HP:0003642) | 1.83868355 |
| 161 | Increased serum pyruvate (HP:0003542) | 1.83777942 |
| 162 | Abnormality of glycolysis (HP:0004366) | 1.83777942 |
| 163 | Increased intramyocellular lipid droplets (HP:0012240) | 1.83492339 |
| 164 | Hyperthyroidism (HP:0000836) | 1.83418641 |
| 165 | Impaired platelet aggregation (HP:0003540) | 1.82425556 |
| 166 | Abnormal platelet function (HP:0011869) | 1.82425556 |
| 167 | Carpal bone hypoplasia (HP:0001498) | 1.82191457 |
| 168 | Combined immunodeficiency (HP:0005387) | 1.82042777 |
| 169 | Degeneration of anterior horn cells (HP:0002398) | 1.81242936 |
| 170 | Abnormality of the anterior horn cell (HP:0006802) | 1.81242936 |
| 171 | Molar tooth sign on MRI (HP:0002419) | 1.81033294 |
| 172 | Abnormality of midbrain morphology (HP:0002418) | 1.81033294 |
| 173 | Petechiae (HP:0000967) | 1.80967665 |
| 174 | Abnormality of the prostate (HP:0008775) | 1.80171934 |
| 175 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.79992737 |
| 176 | Poor suck (HP:0002033) | 1.79747356 |
| 177 | Recurrent fungal infections (HP:0002841) | 1.79645303 |
| 178 | Sandal gap (HP:0001852) | 1.79555597 |
| 179 | Cutis marmorata (HP:0000965) | 1.77636191 |
| 180 | Abnormality of the preputium (HP:0100587) | 1.77442215 |
| 181 | Panhypogammaglobulinemia (HP:0003139) | 1.77283188 |
| 182 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.76388031 |
| 183 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.76388031 |
| 184 | Abnormal protein glycosylation (HP:0012346) | 1.76388031 |
| 185 | Abnormal glycosylation (HP:0012345) | 1.76388031 |
| 186 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.75039187 |
| 187 | Acute necrotizing encephalopathy (HP:0006965) | 1.73607092 |
| 188 | Autoimmune hemolytic anemia (HP:0001890) | 1.71892820 |
| 189 | Abnormality of the labia minora (HP:0012880) | 1.71652908 |
| 190 | Rib fusion (HP:0000902) | 1.70519716 |
| 191 | Pallor (HP:0000980) | 1.69914782 |
| 192 | Anomalous pulmonary venous return (HP:0010772) | 1.68754857 |
| 193 | Polymicrogyria (HP:0002126) | 1.66972929 |
| 194 | Joint swelling (HP:0001386) | 1.66924752 |
| 195 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.66826857 |
| 196 | Enlarged kidneys (HP:0000105) | 1.66131825 |
| 197 | Clubbing of toes (HP:0100760) | 1.65537108 |
| 198 | Increased muscle lipid content (HP:0009058) | 1.63999895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK5 | 5.52703742 |
| 2 | SRPK1 | 3.67023730 |
| 3 | GRK7 | 3.51641529 |
| 4 | INSRR | 3.12941808 |
| 5 | KSR2 | 3.06831161 |
| 6 | ADRBK2 | 3.01558040 |
| 7 | CDK12 | 2.98878145 |
| 8 | NTRK3 | 2.87370693 |
| 9 | MINK1 | 2.79249267 |
| 10 | ZAK | 2.69108766 |
| 11 | LMTK2 | 2.61154076 |
| 12 | TXK | 2.60627179 |
| 13 | GRK6 | 2.53195839 |
| 14 | MAP3K9 | 2.49977889 |
| 15 | FES | 2.44788249 |
| 16 | LATS2 | 2.34557801 |
| 17 | MAP3K2 | 2.31492619 |
| 18 | LIMK1 | 2.27917175 |
| 19 | PLK4 | 2.18076692 |
| 20 | MAPKAPK3 | 2.17085520 |
| 21 | MAP2K4 | 2.16923612 |
| 22 | TLK1 | 2.15330695 |
| 23 | WNK1 | 2.09225507 |
| 24 | ADRBK1 | 2.00229035 |
| 25 | TAOK3 | 1.97909547 |
| 26 | BTK | 1.96457886 |
| 27 | NME1 | 1.96191068 |
| 28 | SCYL2 | 1.95340475 |
| 29 | MAP3K11 | 1.81148610 |
| 30 | ICK | 1.77265619 |
| 31 | MAP4K2 | 1.76578023 |
| 32 | ARAF | 1.76561958 |
| 33 | ERN1 | 1.72904256 |
| 34 | MAP2K1 | 1.64541992 |
| 35 | ITK | 1.59264942 |
| 36 | NUAK1 | 1.51930650 |
| 37 | * NTRK1 | 1.50367930 |
| 38 | RET | 1.49656882 |
| 39 | MAP3K4 | 1.49274019 |
| 40 | BCR | 1.44795435 |
| 41 | EIF2AK1 | 1.41071466 |
| 42 | TEC | 1.39513673 |
| 43 | PHKG2 | 1.36887599 |
| 44 | PHKG1 | 1.36887599 |
| 45 | ATR | 1.33183700 |
| 46 | PKN1 | 1.31827350 |
| 47 | TAOK1 | 1.30452685 |
| 48 | BMPR2 | 1.29661316 |
| 49 | PRKG2 | 1.28951750 |
| 50 | TYRO3 | 1.28926683 |
| 51 | GRK1 | 1.27606921 |
| 52 | PINK1 | 1.27019333 |
| 53 | EPHA3 | 1.22995060 |
| 54 | RIPK4 | 1.22731627 |
| 55 | PRKCQ | 1.22360750 |
| 56 | LCK | 1.17338954 |
| 57 | MAP2K3 | 1.17254049 |
| 58 | MST4 | 1.16566197 |
| 59 | SYK | 1.12934194 |
| 60 | MOS | 1.11525692 |
| 61 | IKBKB | 1.07831398 |
| 62 | DYRK2 | 1.07790666 |
| 63 | PAK6 | 1.04956458 |
| 64 | PRKCG | 1.04874294 |
| 65 | MAP3K12 | 1.03788801 |
| 66 | TAOK2 | 1.03666631 |
| 67 | CLK1 | 1.01948338 |
| 68 | CDC7 | 1.00586749 |
| 69 | MAP3K7 | 0.98897376 |
| 70 | MARK1 | 0.98481874 |
| 71 | MAP3K14 | 0.96915815 |
| 72 | HIPK2 | 0.96597349 |
| 73 | MAPK13 | 0.96367581 |
| 74 | RPS6KA2 | 0.96130941 |
| 75 | BCKDK | 0.93732703 |
| 76 | PLK2 | 0.92519659 |
| 77 | CHEK2 | 0.91379224 |
| 78 | CSF1R | 0.90220532 |
| 79 | PDK2 | 0.89834344 |
| 80 | CDK14 | 0.88975529 |
| 81 | PIM1 | 0.88521463 |
| 82 | MARK2 | 0.86731620 |
| 83 | SGK223 | 0.86119514 |
| 84 | SGK494 | 0.86119514 |
| 85 | TRIM28 | 0.85435429 |
| 86 | FER | 0.85306634 |
| 87 | JAK3 | 0.85243741 |
| 88 | UHMK1 | 0.84153220 |
| 89 | CAMK4 | 0.81556081 |
| 90 | WNK4 | 0.81385855 |
| 91 | DAPK2 | 0.80484953 |
| 92 | WNK3 | 0.80041684 |
| 93 | MAP2K2 | 0.79196976 |
| 94 | MAP2K6 | 0.78695245 |
| 95 | CDK5 | 0.77342797 |
| 96 | TTK | 0.77199881 |
| 97 | MAP4K1 | 0.77010484 |
| 98 | FGFR3 | 0.76605891 |
| 99 | NEK1 | 0.76549884 |
| 100 | MAP2K7 | 0.76513751 |
| 101 | NLK | 0.76479246 |
| 102 | CSNK1A1L | 0.75889009 |
| 103 | MAP3K1 | 0.73678675 |
| 104 | TSSK6 | 0.72517675 |
| 105 | LYN | 0.72191586 |
| 106 | JAK2 | 0.71379621 |
| 107 | PTK2 | 0.69351015 |
| 108 | ATM | 0.69237938 |
| 109 | PRKCE | 0.68696819 |
| 110 | BMX | 0.68679562 |
| 111 | MARK3 | 0.68059073 |
| 112 | CSNK1G2 | 0.66928941 |
| 113 | MAPK7 | 0.66060556 |
| 114 | EIF2AK3 | 0.65929561 |
| 115 | CDK18 | 0.64484317 |
| 116 | CSNK1G3 | 0.64319055 |
| 117 | SIK3 | 0.64260173 |
| 118 | TGFBR2 | 0.62494964 |
| 119 | CDK15 | 0.62219822 |
| 120 | KDR | 0.61848510 |
| 121 | ILK | 0.60198073 |
| 122 | CAMKK2 | 0.59814346 |
| 123 | PAK1 | 0.59249946 |
| 124 | RAF1 | 0.58672182 |
| 125 | RPS6KA5 | 0.55454677 |
| 126 | MAP3K6 | 0.55382465 |
| 127 | IRAK1 | 0.54998776 |
| 128 | CDK4 | 0.54772459 |
| 129 | CDK8 | 0.54346204 |
| 130 | AKT3 | 0.53086126 |
| 131 | TESK1 | 0.52268777 |
| 132 | PDK3 | 0.52190091 |
| 133 | PDK4 | 0.52190091 |
| 134 | CSNK1E | 0.51942594 |
| 135 | WEE1 | 0.51880399 |
| 136 | CDK11A | 0.51701207 |
| 137 | PAK3 | 0.50480638 |
| 138 | HCK | 0.50047223 |
| 139 | ZAP70 | 0.49568590 |
| 140 | VRK1 | 0.48981031 |
| 141 | BRSK2 | 0.48591951 |
| 142 | BRD4 | 0.48180670 |
| 143 | MAPK3 | 0.47260751 |
| 144 | MAPK4 | 0.46960900 |
| 145 | CAMKK1 | 0.45615697 |
| 146 | PRKACG | 0.44329297 |
| 147 | AURKA | 0.44167091 |
| 148 | CDK2 | 0.44148152 |
| 149 | MAPK9 | 0.44103781 |
| 150 | EEF2K | 0.42985506 |
| 151 | PRKACA | 0.42465252 |
| 152 | TIE1 | 0.41704361 |
| 153 | CDK1 | 0.41104821 |
| 154 | ALK | 0.40784622 |
| 155 | PRKACB | 0.40174528 |
| 156 | MAPK11 | 0.40121525 |
| 157 | SGK2 | 0.39507486 |
| 158 | NEK6 | 0.39334661 |
| 159 | PRKCB | 0.39015243 |
| 160 | MAP3K8 | 0.38404533 |
| 161 | NEK2 | 0.38339010 |
| 162 | CASK | 0.38141358 |
| 163 | CSNK1G1 | 0.37983962 |
| 164 | PDGFRA | 0.37549686 |
| 165 | FLT3 | 0.35976239 |
| 166 | MAPK10 | 0.35709501 |
| 167 | PRKCD | 0.31934439 |
| 168 | DAPK1 | 0.30070368 |
| 169 | MAPK12 | 0.29498473 |
| 170 | * SRC | 0.29342133 |
| 171 | MAPK8 | 0.28821021 |
| 172 | RIPK1 | 0.25915292 |
| 173 | NTRK2 | 0.25871214 |
| 174 | YES1 | 0.25853575 |
| 175 | CAMK2G | 0.24850090 |
| 176 | PRKCI | 0.24571636 |
| 177 | BRAF | 0.24531072 |
| 178 | MAPKAPK5 | 0.24264634 |
| 179 | PDK1 | 0.23579101 |
| 180 | TESK2 | 0.23353894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 3.63703102 |
| 2 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.16269603 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.15709151 |
| 4 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 3.08973924 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.06064232 |
| 6 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.86231640 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.78174220 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.74036742 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.72065079 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.64509952 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.34848967 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.06099857 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 2.05371759 |
| 14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.03582345 |
| 15 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 2.02728788 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 2.01461915 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.96393722 |
| 18 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.95450673 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 1.93572979 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.92965530 |
| 21 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.87964102 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.84487211 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.84055199 |
| 24 | DNA replication_Homo sapiens_hsa03030 | 1.76855581 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.76283960 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.70967922 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.70014873 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.68811325 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.68475896 |
| 30 | Mismatch repair_Homo sapiens_hsa03430 | 1.67290841 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.60153114 |
| 32 | Insulin secretion_Homo sapiens_hsa04911 | 1.58971291 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.58904599 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.57824683 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.54058512 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.53058963 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51325417 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.47810649 |
| 39 | Long-term potentiation_Homo sapiens_hsa04720 | 1.47479395 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.47433367 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.41130932 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.40644961 |
| 43 | Long-term depression_Homo sapiens_hsa04730 | 1.40351750 |
| 44 | Alcoholism_Homo sapiens_hsa05034 | 1.40074785 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35203551 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.32801598 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.30996248 |
| 48 | Protein export_Homo sapiens_hsa03060 | 1.30626281 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29866572 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28790763 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28684495 |
| 52 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27595699 |
| 53 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.27549169 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25185196 |
| 55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.24295036 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23705272 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21943481 |
| 58 | Cell cycle_Homo sapiens_hsa04110 | 1.21503373 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21413349 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21386130 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 1.21335603 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20484071 |
| 63 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.19732288 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19586288 |
| 65 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.19552591 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 1.19040140 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18462365 |
| 68 | Cocaine addiction_Homo sapiens_hsa05030 | 1.15890661 |
| 69 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.15439318 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13209755 |
| 71 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.12482940 |
| 72 | Renin secretion_Homo sapiens_hsa04924 | 1.12236071 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.11964325 |
| 74 | Circadian entrainment_Homo sapiens_hsa04713 | 1.09741531 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 1.08027726 |
| 76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.02546394 |
| 77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.01717576 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 1.00208580 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.99461765 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.98108728 |
| 81 | * Thyroid cancer_Homo sapiens_hsa05216 | 0.97845049 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97687114 |
| 83 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97395346 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97281762 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96255255 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96095147 |
| 87 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.95715453 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.94968770 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94929914 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93625165 |
| 91 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92373473 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.89174135 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88663890 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87998499 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86543141 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85828829 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85635536 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82949573 |
| 99 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82798007 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82635324 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.82247431 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81884691 |
| 103 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81140316 |
| 104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.80991087 |
| 105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.79770935 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79538935 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.79054358 |
| 108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78659193 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77272313 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75993157 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75828182 |
| 112 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74939385 |
| 113 | Melanogenesis_Homo sapiens_hsa04916 | 0.74828162 |
| 114 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73725918 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.73721490 |
| 116 | Axon guidance_Homo sapiens_hsa04360 | 0.72917653 |
| 117 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72464881 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72044709 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70904616 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.70659545 |
| 121 | Phototransduction_Homo sapiens_hsa04744 | 0.70113710 |
| 122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70108309 |
| 123 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69164218 |
| 124 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68514273 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68256331 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68020282 |
| 127 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67835344 |
| 128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66069696 |
| 129 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65459576 |
| 130 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65009508 |
| 131 | Base excision repair_Homo sapiens_hsa03410 | 0.63012261 |
| 132 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61765551 |
| 133 | Shigellosis_Homo sapiens_hsa05131 | 0.60602815 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60462569 |
| 135 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60191588 |
| 136 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58890569 |
| 137 | * Apoptosis_Homo sapiens_hsa04210 | 0.58520669 |
| 138 | Phagosome_Homo sapiens_hsa04145 | 0.58418944 |
| 139 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58409900 |
| 140 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58392040 |
| 141 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58379568 |
| 142 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.57897442 |
| 143 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57890164 |
| 144 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56546901 |
| 145 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55469863 |
| 146 | Melanoma_Homo sapiens_hsa05218 | 0.55214030 |
| 147 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54877402 |
| 148 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54330787 |
| 149 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53464612 |
| 150 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53154574 |
| 151 | Proteasome_Homo sapiens_hsa03050 | 0.52966046 |
| 152 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51788381 |
| 153 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.51088849 |
| 154 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50926732 |
| 155 | Ribosome_Homo sapiens_hsa03010 | 0.50474654 |
| 156 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50275190 |
| 157 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50061845 |
| 158 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48932096 |
| 159 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48899351 |
| 160 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47903286 |
| 161 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46983139 |
| 162 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44496210 |
| 163 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43967190 |
| 164 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43803361 |
| 165 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43590305 |
| 166 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43363044 |
| 167 | Morphine addiction_Homo sapiens_hsa05032 | 0.43204221 |
| 168 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42670211 |
| 169 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42484154 |
| 170 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.42477956 |
| 171 | Salmonella infection_Homo sapiens_hsa05132 | 0.42208845 |
| 172 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41604878 |
| 173 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40792014 |
| 174 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40119763 |
| 175 | Platelet activation_Homo sapiens_hsa04611 | 0.37544494 |
| 176 | Hepatitis B_Homo sapiens_hsa05161 | 0.35166555 |
| 177 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.32018253 |

